Elanco Animal Health Price to Book Ratio 2016-2026 | ELAN
Historical price to book ratio values for Elanco Animal Health (ELAN) over the last 10 years. The current price to book ratio for Elanco Animal Health as of September 15, 2026 is 1.74.
| Elanco Animal Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 22.86 | 1.73 | |
| 2026-06-30 | 24.61 | $13.19 | 1.87 |
| 2026-03-31 | 23.93 | $13.02 | 1.84 |
| 2025-12-31 | 22.63 | $13.17 | 1.72 |
| 2025-09-30 | 20.14 | $13.58 | 1.48 |
| 2025-06-30 | 14.28 | $13.64 | 1.05 |
| 2025-03-31 | 10.50 | $12.80 | 0.82 |
| 2024-12-31 | 12.11 | $12.33 | 0.98 |
| 2024-09-30 | 14.69 | $13.20 | 1.11 |
| 2024-06-30 | 14.43 | $12.02 | 1.20 |
| 2024-03-31 | 16.28 | $12.26 | 1.33 |
| 2023-12-31 | 14.90 | $12.63 | 1.18 |
| 2023-09-30 | 11.24 | $12.45 | 0.90 |
| 2023-06-30 | 10.06 | $15.06 | 0.67 |
| 2023-03-31 | 9.40 | $15.19 | 0.62 |
| 2022-12-31 | 12.22 | $15.37 | 0.80 |
| 2022-09-30 | 12.41 | $14.23 | 0.87 |
| 2022-06-30 | 19.63 | $15.06 | 1.30 |
| 2022-03-31 | 26.09 | $16.06 | 1.62 |
| 2021-12-31 | 28.38 | $15.87 | 1.79 |
| 2021-09-30 | 31.89 | $16.24 | 1.96 |
| 2021-06-30 | 34.69 | $16.87 | 2.06 |
| 2021-03-31 | 29.45 | $16.93 | 1.74 |
| 2020-12-31 | 30.67 | $17.96 | 1.71 |
| 2020-09-30 | 27.93 | $17.68 | 1.58 |
| 2020-06-30 | 21.45 | $16.68 | 1.29 |
| 2020-03-31 | 22.39 | $16.70 | 1.34 |
| 2019-12-31 | 29.45 | $14.87 | 1.98 |
| 2019-09-30 | 26.59 | $14.71 | 1.81 |
| 2019-06-30 | 33.80 | $14.40 | 2.35 |
| 2019-03-31 | 32.07 | $14.21 | 2.26 |
| 2018-12-31 | 31.53 | $14.21 | 2.22 |
| 2018-09-30 | 34.89 | $14.05 | 2.48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.491B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |